- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Alivus Life Sciences Limited — Updates, 18-08-2026: Press Release
18-08-2026 | 05:35 pm
18-08-2026 | 05:35 pm
Alivus Life Sciences acquired 76% of IQGenX Pharma for INR 9.12 Cr. This expands Alivus's capabilities into advanced formulation development, integrating an end-to-end platform. It boosts CDMO services and leverages API expertise for global market access and strategic asset out-licensing.
No comments yet. Be the first to comment!